IGF2BP3 and hepatocellular carcinoma: Similar to the results shown in Figure 2B, western blot analysis indicated that d-ICD treatment decreased ABCB1, ABCG2 and CD133 protein expression but that IGF2BP3 upregulation nearly completely abolished this effect of d-ICD on HCC cells (Figure 4D).